Sep 09, 2019 / 01:55PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Pleased to have Biogen with me.
Before we get started, I just need to read a disclosure statement, and that is, please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk.
So I'm very pleased to have with me Jeff Capello, who's the CFO of Biogen. And Jeff, I thought I'd give you the opportunity to make some opening comments, and then we can jump into it.
Jeffrey D. Capello - Biogen Inc. - Executive VP & CFO
Great. Thank you, Matthew. Thank you to Morgan Stanley for having us at the conference this year, and we appreciate your interest in Biogen.
Before we start, I just want to share with you that I'm sure we'll get into
Biogen Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers